Gly389Arg polymorphism of β1-adrenergic receptor is associated with the cardiovascular response to metoprolol

Clinical Pharmacology and Therapeutics

Volumn 74, Issue 4, 2003, Pages 372-379

  Liu, Jie ^a   Liu, Zhao Qian ^a   Tan, Zhi Rong ^a   Chen, Xiao Ping ^a   Wang, Lian Sheng ^a   Zhou, Gan ^a   Zhou, Hong Hao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA 1 ADRENERGIC RECEPTOR; GLYCINE; METOPROLOL; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE CALCULATION; DOSE RESPONSE; DRUG BLOOD LEVEL; FUNCTIONAL ASSESSMENT; GENETIC DIFFERENCE; HEART OUTPUT; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; INTERMETHOD COMPARISON; MALE; MEASUREMENT; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; DRUG EFFECT; EXERCISE; GENETIC POLYMORPHISM; GENETICS; GENOMICS; GENOTYPE; PHARMACOGENETICS;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; EXERCISE; GENOMICS; GENOTYPE; HEART RATE; HUMANS; MALE; METOPROLOL; PHARMACOGENETICS; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-1;

EID: 0141525465     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(03)00224-8     Document Type: Article

References (33)

1. Vesell ES. Advances in pharmacogenetics and pharmacogenomics. J Clin Pharmacol 2000;40:930-8.
2. Ambrosioni E, Bacchelli S, Esposti DD, Borghi C. Beta-blockade in hypertension and congestive heart failure. J Cardiovasc Pharmacol 2001;38(Suppl 3):S25-31.
3. Lund-Johansen P, Ohm OJ. Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension. Br J Clin Pharmacol 1977;4:147-51.
4. Falase AO, Salako LA. Beta-adrenoceptor blockers in the treatment of hypertension. Afr J Med Sci 1979;8:13-8.
5. Clausen N, Damsgaard T, Mellemgaard K. Antihypertensive effect of a non-selective (propranolol) and a cardio-selective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise. Br J Clin Pharmacol 1979;7: 379-83.
6. Venter CP, Joubert PH. Ethnic differences in response to beta 1-adrenoceptor blockade by propranolol. J Cardiovasc Pharmacol 1984;6:361-4.
7. Venter CP, Joubert PH, Strydom WJ. The relevance of ethnic differences in hemodynamic responses to the head-up tilt manoeuvre to clinical pharmacological investigations. J Cardiovasc Pharmacol 1985;7:1009-10.
8. Zhou HH, Koshakji RP, Silberstein DJ, Wilkinson GR, Wood AJJ. Racial differences in drug response: altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med 1989;320:565-70.
9. Lennard MS, Silas JH, Freestone S, Ramsay LE, Tucker GT, Woods HF. Oxidation phenotype: a major determinant of metoprolol metabolism and response. N Engl J Med 1982;307:1158-60.
10. Castleden CM, Kaye CM, Parsons RL. The effect of age on plasma levels of propranolol and practolol in man. Br J Clin Pharmacol 1975;2:303-6.
11. Vestal RE, Wood AJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979;26:181-6.
12. Vestal RE, Wood AJ, Branch RA, Shand DG, Wilkinson GR. Effects of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther 1979;26:8-15.
13. Feely J, Crooks J, Stevenson IH. The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration. Br J Clin Pharmacol 1981;12: 73-8.
14. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994;33:9414-9.
15. Martinez FD, Graves P E, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta-2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997;100:3184-8.
16. 1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med 2000;78:87-93.
17. 1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 2002;39:155-60.
18. 1-radrenergic receptor. J Biol Chem 1999;274:12670-4.
19. Borjesson M, Magnusson Y, Hjalmarson A, Andersson B. A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 2000;21:1853-8.
20. 1-adrenoceptor: identification and rapid screening assay [letter]. Lancet 1999;353:897.
21. 1-adrenergic receptor polymorphisms: analysis of c145A→G and c1165G→C. Hum Mutat 1999;14:271.
22. 1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol 1999;31:1025-32.
23. Sofowora GG, Dishy V, Muszkat M, Xie HG, Kim RB, Harris PA, et al. A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade. Clin Pharmacol Ther 2003;73: 366-71.
24. 1-Adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 2003;74:44-52.
25. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1989.
26. Johnson M. The beta-adrenoceptor. Am J Respir Crit Care Med 1998;158(5 Pt 3):S146-53.
27. Motomura S, Reinhard-Zerkowski H, Daul A, Brodde OE. On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies. Am Heart J 1990;119(3 Pt 1):608-19.
28. 1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol 2001;88:1034-7.
29. 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 2001;11:191-7.
30. 1-adrenoceptor polymorphism in humans. Pharmacogenetics 2001;11:199-205.
31. Krukemyer JJ. Use of beta-adrenergic blocking agents in congestive heart failure. Clin Pharm 1990;9:853-63.
32. De Servi S, Ferrario M, Ghio S, Cioffi P, Angoli L, Bramucci E, et al. Variable response to atrial pacing after intravenous propranolol in patients with stable exertional angina. Eur Heart J 1990;11:997-1005.
33. Zhou HH, Wood AJJ. Increased suppression of exercise-induced increase in renin by propranolol in Chinese subjects. Clin Pharmacol Ther 1991;50:150-6.